In cyclophosphamide (CYP)-induced cystitis, intrathecal injection of either a general Trk receptor antagonist or a BDNF scavenger reduces bladder hyperactivity and also reduces spinal extracellular signal-regulated kinase (ERK) phosphorylation [31]. This evidence concerns the gene BDNF and cystitis.